Steady-state serum T3 concentrations for 48 hours following the oral administration of a single dose of 3,5,3'-triiodothyronine sulfate (T 3S)

Endocrine Practice

Volumn 20, Issue 7, 2014, Pages 680-689

  Santini, Ferruccio ^a   Giannetti, Monica ^a   Ricco, Ilaria ^a   Querci, Giorgia ^a   Saponati, Giorgio ^b   Bokor, Daniela ^c   Rivolta, Giovanni ^c   Bussi, Simona ^c   Braverman, Lewis E ^d   Vitti, Paolo ^a   Pinchera, Aldo ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b Ispharm CRO   (Italy)

^c Bracco SpA   (Italy)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; LIOTHYRONINE; LIOTHYRONINE SULFATE; TRIIODOTHYRONINE DERIVATIVE; UNCLASSIFIED DRUG; TRIIODOTHYRONINE SULFATE;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BILIARY EXCRETION; CLINICAL ARTICLE; CONJUGATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; PHASE 1 CLINICAL TRIAL (TOPIC); SINGLE DRUG DOSE; STEADY STATE; URINARY EXCRETION; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TIME FACTOR;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TRIIODOTHYRONINE;

EID: 84904973346     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13331.OR     Document Type: Article

References (28)

1. Otten MH, Mol JA, Visser TJ. Sulfation preceding Deiodination of iodothyronines in rat hepatocytes. Science. 1983;221:81-83
2. Visser TJ, Mol JA, Otten MH. Rapid Deiodination of triiodothyronine sulfate by rat liver microsomal fraction. Endocrinology. 1983;112:1547-1549
3. Rooda SJ, Kaptein E, Rutgers M, Visser TJ. Increased plasma 3,5,3'-triiodothyronine sulfate in rats with inhibited type I iodothyronine Deiodinase activity, as measured by radioimmunoassay. Endocrinology. 1989;124:740-745
4. Chopra IJ, Wu SY, Teco GN, Santini F. A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. J Clin Endocrinol Metab. 1992;75: 189-194
5. Santini F, Cortelazzi D, Baggiani AM, Marconi AM, Beck-Peccoz P, Chopra IJ. A study of the serum 3,5,3'-triiodothyronine sulfate concentration in normal and hypothyroid fetuses at various gestational stages. J Clin Endocrinol Metab. 1993;76:1583-1587
6. Santini F, Chiovato L, Bartalena L, et al. Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol. 1996;134:45-49
7. Spaulding SW, Smith TJ, Hinkle PM, Davis FB, Kung MP, Roth JA. Studies on the biologiCAl activity of triiodothyronine sulfate. J Clin Endocrinol Metab. 1992;74: 1062-1067
8. Kung MP, Spaulding SW, Roth JA. Desulfation of 3,5,3'-triiodothyronine sulfate by microsomes from human and rat tissues. Endocrinology. 1988;122:1195-1200
9. Santini F, Chopra IJ, Wu SY, Solomon DH, Chua Teco GN. Metabolism of 3,5,3'-triiodothyronine sulfate by tissues of the fetal rat: a consiDeration of the role of Desulfation of 3,5,3'-triiodothyronine sulfate as a source of T3. Pediatr Res. 1992;31:541-544
10. Santini F, Hurd RE, Lee B, Chopra IJ. Sex-related differences in iodothyronine metabolism in the rat: eviDence for differential regulation among various tissues. Metabolism. 1994;43:793-797
11. Rutgers M, HeusDens FA, Bonthuis F, De HerDer WW, Hazenberg MP, Visser TJ. Enterohepatic circulation of triiodothyronine (T3) in rats: importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates. Endocrinology. 1989;125:2822-2830
12. Santini F, Hurd RE, Lee B, Chopra IJ. Thyromimetic effects of 3,5,3'-triiodothyronine sulfate in hypothyroid rats. Endocrinology. 1993;133:105-110
13. LoPresti JS, Mizuno L, Nimalysuria A, AnDerson KP, Spencer CA, Nicoloff JT. Characteristics of 3,5,3'-triiodothyronine sulfate metabolism in euthyroid man. J Clin Endocrinol Metab. 1991;73:703-709
14. LoPresti JS, Nicoloff JT. 3,5,3'-Triiodothyronine (T3) sulfate: a major metabolite in T3 metabolism in man. J Clin Endocrinol Metab. 1994;78:688-692
15. ICH Topic Q6A. Note for guidance specifiCAtions: test procedures and acceptance criteria for new drugs substances and new drug products: chemiCAl substances (CPMP/ICH/367/96). Available at: http://www.emea.europa. eu/docs/en-GB/document-library/Scientific-guiDeline/2009/09/WC500002823.pdf. Accessed May 7, 2014
16. Marsili A, Santini F, Fierabracci P, et al. Kinetics, bioactivity and tolerability of 3,5,3'-triiodothyronine (T3) in an oral solution in thyroiDectomized patients. J Endocrinol Invest. 2005;28:356-357
17. Eisenberg MC, Santini F, Marsili A, Pinchera A, DiStefano JJ 3rd. TSH regulation dynamics in central and extreme primary hypothyroidism. Thyroid. 2010;20: 1215-1228
18. Santini F, Hurd RE, Chopra IJ. A study of metabolism of Deaminated and sulfoconjugated iodothyronines by rat placental iodothyronine 5-monoDeiodinase. Endocrinology. 1992;131:1689-1694
19. Spaulding SW. Bioactivity of sulfoconjugated iodothyronines. In: Wu SY, Visser TJ, eds. Thyroid Hormone Metabolism. Molecular Biology and Alternate Pathways. BoCA Raton, FL: CRC Press; 1994: 139-153
20. Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970;49:855-864
21. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002;25:106-109
22. Gullo D, Latina A, FrasCA F, Le Moli R, Pellegriti G, Vigneri R. Levothyroxine monotherapy CAnnot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6:e22552
23. Escobar-Morreale HF, Botella-CArretero JI, Escobar Del Rey F, Morreale De Escobar G. Review: treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005;90:4946-4954
24. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for cliniCAl hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2006; 91:2592-2599
25. Pinchera A, Santini F. Commentary. Nature Clin Pract Endocrinol Metab. 2005;1:19
26. Garber JR, Cobin RH, Gharib H, et al. CliniCAl practice guiDelines for hypothyroidism in adults: cosponsored by the American Association of CliniCAl Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18:988-1028
27. Wiersinga WM, Duntas L, FaDeyev V, Nygaard B, VanDerpump MP. 2012 ETA guiDelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1:55-71
28. McDermott M. Does combination T4 and T3 therapy make sense? Endocr Pract. 2012;18:750-757.